Overview
Jeremy Force is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Force is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. Dr. Force is currently accepting new patients.
His clinical research consists of co-authoring 33 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Inflammatory Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- POS
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Wakemed Specialists Group LLC
Mark Graham is a Hematologist Oncology specialist and a Hematologist in Cary, North Carolina. Dr. Graham is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Bone Marrow Aspiration, and Endoscopy. Dr. Graham is currently accepting new patients.
Hyman Muss is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Muss is rated as a Distinguished provider by MediFind in the treatment of Inflammatory Breast Cancer. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.
Duke Cancer Center
I am a medical oncologist, a physician providing medical treatments to cancer patients, drawn to this field by the profound relationships we foster with our patients and the dynamic scientific advancements. Building individual connections allows us to tailor care to our patients' unique needs and accompany them throughout their journey. Additionally, we contribute to pioneering new treatments, offering hope and reduced treatment-related toxicity with each passing day. Outside of work, I find joy in traveling, knitting, and cherishing moments with family. Exploring North Carolina holds a special place in my heart, as I delight in discovering more about its intricacies. Dr. Thomas is rated as an Advanced provider by MediFind in the treatment of Inflammatory Breast Cancer. Her top areas of expertise are Angiosarcoma, Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Force isElite. Learn about Breast Cancer.
- Distinguished
- AngiosarcomaDr. Force isDistinguished. Learn about Angiosarcoma.
- Inflammatory Breast CancerDr. Force isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Force isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Breast Cancer in MenDr. Force isAdvanced. Learn about Breast Cancer in Men.
- HER-2 Positive Breast CancerDr. Force isAdvanced. Learn about HER-2 Positive Breast Cancer.
- Triple-Negative Breast CancerDr. Force isAdvanced. Learn about Triple-Negative Breast Cancer.
- Experienced
- BRCA Positive Breast CancerDr. Force isExperienced. Learn about BRCA Positive Breast Cancer.
- Caffey DiseaseDr. Force isExperienced. Learn about Caffey Disease.
- Intraductal PapillomaDr. Force isExperienced. Learn about Intraductal Papilloma.